References
- Statistics Norway. 2010. Retrieved May 21, 2011, from: http://www.ssb.no./emner/06/02/
- Bergström G, Bergström C, Hagberg J, Bodin L, Jensen I: A 7-year follow-up of multidisciplinary rehabilitation among chronic neck and back patients. Is sick leave outcome dependent on psychological derived patient groups? Eur J Pain 14: 426–433, 2010
- Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D: Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain 10: 287–333, 2006
- Anderson IH: The course of non-malignant chronic pain: A 12-year follow-up of a cohort from the general population. Eur J Pain 8: 47–53, 2004
- Kamaleri Y, Natvig B, Ihlebæk CM, Benth JS, Bruusgaard D: Number of pain sites is associated with demographic, lifestyle, and health-related factors in the general population. Eur J Pain 12: 742–748, 2008
- Lillefjell M, Jakobsen K, Krokstad S: Utsatte grupper – karakteristika og utfordringer på arbeidsmarkedet. Tidskrift for Velferdsforskning 13: 107–118, 2010 [in Norwegian]
- Hausken AM, Furu K, Tverdal AA, Skurtveit S: Mental distress and subsequent use of anxiolytic drugs – A prospective population-based cohort study of 16,000 individuals. Scand J Public Health 38: 465–473, 2010
- Kelly JP, Cook SF, Kaufman DW, Anderson T, Rosenberg L, Mitchell AA: Prevalence and characteristics of opioid use in the US adult population. Pain 138: 507–513, 2008
- NorPD [database online]. The Norwegian Prescription Database 2004–2010. Oslo: National Institute of Public Health. Updated, 2010
- Fredheim OM, Skurtveit S, Breivik H, Borchgrevink P: Increasing use of opioids from 2004–2007 – Pharmacoepidemiological data from a complete national prescription database in Norway. Eur J Pain 14: 289–294, 2010
- Eriksen J, Sjögren P, Bruera E, Ekholm O, Rasmussen NK: Critical issues on opioids in chronic non-cancer pain: An epidemiological study. Pain 125: 172–179, 2006
- Hartz I, Lundesgaard E, Tverdal A, Skurtveit S: Disability pension as a predictor of later use of bezodiazepines among benzodiazepine users. Scand J Public Health 37: 320–326, 2009
- Hartz I, Tverdal Aa, Skille E, Skurtveit S: Disability pension is associated with the use of benzodiazepines 20 years later – A prospective study. Soc Sci Med 70: 921–925, 2010
- O’Brian CP: Benzodiazepine use, abuse, and dependence. J Clin Psychiatry 66: 28–33, 2005
- Barker MJ, Greenwood KM, Jackson M, Crowe SF: Cognitive effects of long-term benzodiazepine use: A meta-analysis. CNS Drugs 18: 37–48, 2004
- WHO Collaborating Centre for Drug Statistics Methodology: ATC Classification Index with DDDs, WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway, 2006, pp. 1–282
- Turk DC, Swanson KS, Gatchel RJ: Predicting opioid misuse by chronic pain patients: A systematic review and literature synthesis. Clin J Pain 24: 497–508, 2008
- Lillefjell M: Function and work ability following multidisciplinary rehabilitation for individuals with chronic musculoskeletal pain. Doctoral theses at NTNU184, 2008, pp. 1–83
- Wigers S, Finset A: Rehabilitering ved kroniske myofascielle smertetilstander. Tidsskr Nor Laegeforen 5: 604–608, 2007 [in Norwegian]
- Braathen TN, Veiersted KB, Heggenes J: Improved work ability and return to work following vocational multidisciplinary rehabilitation of subjects on long-term sick leave. J Rehabil Med 39: 493–499, 2007
- McCracken LM, MacKichan F, Eccleston C: Contextual cognitive-behavioral therapy for several disabled chronic pain suffers: Effectiveness and clinically significant change. Eur J Pain 11: 314–322, 2007
- McCracken LM, Turk DC: Behavioural and cognitive-behavioural treatment for chronic pain: Outcome, predictors of outcome, and treatment. Spine 22: 2564–2573, 2002
- Truchon M: Determinants of chronic disability related to low back pain: Towards an integrative biopsychosocial model. Disabil Rehabil 23: 758–767, 2001
- Demyttenaere K, Bonnewyn A, Bruffaerts R, De Girolamo G, Gasquet I, Kovess V, Haro JM, Alonso J: Clinical factors influencing the prescription of antidepressants and benzodiazepines: Results from the European study of the epidemiology of the mental disorders [ESEMeD]. J Affect Disord 110: 84–93, 2008
- Hausken AM, Skurtveit S, Rosvold EO, Bramness JG, Furu K: Psychtropic drug useamong persons with mental distress symptoms: A population-based study in Norway. Scand J Public Health 35: 356–364, 2007
- Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R: Psychotropic drug utilization in Europe: Results from the European Study of the Epidemiology of Mental Disorders [ESEMeD] project. Acta Psychiatr Scand Suppl 420: 55–64, 2004
- Engel GL: The need for a new medical model: a challenge for biomedicine. Science 196: 129–136, 1977
- Bowling A: Measuring health. A review of quality of life measurement scales, Open University Press, Buckingham and Philadelphia, 1997, pp. 30–390
- McDowell I, Newell C: Measuring health – A guide to rating scales and questionnaires, Oxford University Press, New York, 1997, pp. 273–517
- Bentsen BG, Natvig B, Winnem M: Assesment of own functional capacity. COOP-WONCA Charts in clinical work and research. Tidsskr Nor Laegeforen 117: 545–549, 1997
- Mykletun A, Stordal E, Dahl AA: Hospital anxiety and depression [HAD] scale: Factor structure, its analyses and internal consistency in a large population. Br J Psychiatry 179: 540–544, 2001
- Frischenschlager O, Pucher I: Psychological management of pain. Disabil Rehabil 8: 416–422, 2002
- Lillefjell M, Krokstad S, Espnes GA: Prediction of function in daily life following multidisciplinary rehabilitation for individuals with chronic musculoskeletal pain; a prospective study. BMC Musculoskeletal Disorders [serial online]. Retrieved June 20, 2011, from: http://www.biomedcentral.com/1471-2474/8/65
- Gatchel RJ: Psychosocial factors that can influence the self-assessment of function. J Occup Rehabil 14: 197–206, 2004